Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Prospective Multi-Center Trial for FemBloc Permanent Birth Control

NCT: NCT05977751 · RECRUITING

NCT IDNCT05977751
StatusRECRUITING
Start Date2023-10-31
Completion2031-06
SponsorFemasys Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

Prospective, multi-center, international, unblinded, single-arm trial of subjects undergoing FemBloc followed by ultrasound confirmation test.

Frequently Asked Questions

What is Prospective Multi-Center Trial for FemBloc Permanent Birth Control?

Prospective Multi-Center Trial for FemBloc Permanent Birth Control is a clinical trial registered under NCT05977751. Current status: RECRUITING.

What is the status of NCT05977751?

The current status of NCT05977751 (Prospective Multi-Center Trial for FemBloc Permanent Birth Control) is: RECRUITING.

When did Prospective Multi-Center Trial for FemBloc Permanent Birth Control start?

Prospective Multi-Center Trial for FemBloc Permanent Birth Control started on 2023-10-31.

Related Devices

K231730FemaSeed Intratubal InseminationFemasys, Inc. K241693FemChec Controlled Saline-Air Device (FCD-250)Femasys, Inc. K242002FemVue MINI Saline-Air DeviceFemasys, Inc. K253403FemVue® Controlled Saline-Air Device (FSA-300)Femasys, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑